Quin is pioneering a new era of direct-to-consumer Virtual Care 2.0 for diabetes that doesn’t rely on human healthcare professionals. Unlike existing diabetes platforms, which add a digital veneer to already ineffective analogue healthcare models, Quin goes deep into the 24x7 needs of the individual living with the condition. Their groundbreaking personalization model empowers people to better manage on their own, when they’re away from their doctors and living their day-to-day life — where 99.9% of diabetes care actually happens. The first Quin app is a novel digital therapeutic for personalized independent self-management of type 1 diabetes. It regularly ranks in the top #1-3 most-downloaded diabetes apps in the App Store in the UK and Ireland. 96% of Quin users experience better health outcomes or wellbeing, or both. Early data shows a massive opportunity to improve time-in-range (a critical healthcare metric) by 10-20% for those starting at less than 70%.

BeatO is a developer of a health monitoring application that helps diabetic patients to track their glucose levels. The company's application provides a full-stack diabetes management program that helps the user manage exercising, diet, medicine intake, and diagnosis, and connects the users with doctors and diabetes educators for instant real-time guidance. Founded in 2015 by Gautam Chopra, Yash Sehgal, Kunal Kinalekar, and Abhishek Kumar, BeatO is headquartered in New Delhi, Delhi.

Using AI, we leverage and harness your knowledge, your experience and the data you input into Quin to surface the information you need at the right time, at a glance. Quin gives you information you can trust because it came from your experience.

Seen in pictures - BeatO, co-founders during the award ceremony and in an interaction with Prime Minister Narendra Modi Ji on the topic of 'Innovation for New India'.